Insider · CIK 0001609805
Ran Nussbaum
Files at KROS (Keros Therapeutics, Inc.), LBRX (LB PHARMACEUTICALS INC). First filing Sep 16, 2025, latest Sep 16, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LBRX: LB PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | LB PHARMACEUTICALS INC | $15M 1,000,000 shares | +243% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | CConversion Common Stockindirect: See footnote | +411,681 | - | - | 411,681 | Sep 16, 2025 |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | POpen-market purchase Common Stockindirect: See footnote | +1,000,000 | $15.00 | $15M | 1,411,681 | Sep 16, 2025 |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | CConversion Series C Preferred Stockderivativeindirect: See footnotes | -10,000,000 | - | - | 0 | Sep 16, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +22,449 | $0.00 | $0 | 22,449 | Sep 12, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Common Stock | +5,250 | $0.00 | $0 | 5,250 | Jun 6, 2025 |
| Jun 4, 2025 | KROS Keros Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,500 | $0.00 | $0 | 10,500 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.